Pablo Lapuerta
2017
In 2017, Pablo Lapuerta earned a total compensation of $1.1M as Executive Vice President and Chief Medical Officer at Lexicon Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,233 |
|---|---|
| Option Awards | $424,303 |
| Salary | $394,604 |
| Stock Awards | $149,310 |
| Other | $11,609 |
| Total | $1,080,059 |
Lapuerta received $424.3K in option awards, accounting for 39% of the total pay in 2017.
Lapuerta also received $100.2K in bonus, $394.6K in salary, $149.3K in stock awards and $11.6K in other compensation.
Rankings
In 2017, Pablo Lapuerta's compensation ranked 8,620th out of 14,666 executives tracked by ExecPay. In other words, Lapuerta earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,620 out of 14,666 | 41st |
Division Manufacturing | 3,274 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,099 out of 2,075 | 47th |
Industry group Drugs | 871 out of 1,731 | 50th |
Industry Pharmaceutical Preparations | 682 out of 1,333 | 49th |
Source: SEC filing on March 16, 2018.
Lapuerta's colleagues
We found four more compensation records of executives who worked with Pablo Lapuerta at Lexicon Pharmaceuticals in 2017.
2017
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2017
Praveen Tyle
Lexicon Pharmaceuticals
Executive Vice President, Research and Development
2017
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2017
Alexander Santini
Lexicon Pharmaceuticals